Course Description

Cost: Free;  Over the Counter drug manufacturers have been cited in recent years for significant compliance failures. A number of companies have managed product recalls and suffered a rapid loss of confidence by both customers and regulators, and it will take these companies years to recover. The FDA 483 observations cited by the Agency cover Quality Systems, Procedures, Specifications and a long list of other weaknesses. The majority of the issues cited by the Agency can be avoided if companies pursue a proactive,

Learn More